DiscGenics -Therapy Discogenic Cell
DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we believe will be a profound therapeutic option for millions of patients suffering from the debilitating effects of low back pain.
Our patented cell culture manufacturing process begins with isolating cells from donated intervertebral disc tissue and results in highly specialized Discogenic Cells that are specifically engineered to uniquely address the complex environment of the degenerated disc.
This approach enables us to introduce to the affected disc therapeutic progenitor cells that originated from, and have many of the same properties as, the precise cell type they are designed to regenerate.
We hypothesize that Discogenic Cells will facilitate regeneration of disc tissue and reduce pain due to inflammation within the degenerated disc.